title: In vitro and in vivo responses of doxorubicin ion exchange microspheres to hyperthermia.
abstract: The utility of microspheres as targeted drug delivery agents is addressed with reference to using heat during formulation and to administration in combination with hyperthermia. It was demonstrated that rate of loading of the drug doxorubicin onto resin microspheres is enhanced under conditions of elevated temperature but this was shown to increase the incidence of microsphere aggregation. Total amount of drug loaded was related to time rather than temperature such that low temperature loading for up to 24 h produced optimum quality injectates. However, release of doxorubicin from microspheres was significantly increased during elevations of temperature to 43 degrees C. Thus, during hyperthermia doxorubicin release can be increased to provide periods of high drug availability targeted to tumour tissue for concomitant thermochemotherapy with microspheres. The therapeutic benefit derived from this combined therapy was assessed in 20 rabbits with VX2 carcinoma implanted in the liver. Hyperthermia was delivered by 2450 MHz microwave applicator to the exteriorized liver at 43 degrees C for 30 min, while chemotherapy was administered by intratumoural injection of doxorubicin microspheres (2.3 mg) into each tumour. Both hyperthermia and chemotherapy alone significantly reduced the size of tumours 10 days following treatment (p less than 0.01). However, in animals treated with both modalities, the size of tumours was significantly less than either treatment alone (p less than 0.05). These results provide a strong rationale for combining hyperthermia with targeted chemotherapy using microspheres.
authors.affiliation: University of Western Australia, Department of Surgery, Royal Perth Hospital.
authors.forename: M A
authors.initials: MA
authors.lastname: Burton
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: H
authors.initials: H
authors.lastname: Atkinson
authors.forename: J P
authors.initials: JP
authors.lastname: Codde
authors.forename: S K
authors.initials: SK
authors.lastname: Jones
authors.forename: B N
authors.initials: BN
authors.lastname: Gray
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D005069:Evaluation Studies as Topic; D005260:Female; D006979:Hyperthermia, Induced; D066298:In Vitro Techniques; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000628:therapy*; D008297:Male; D008863:Microspheres; D011817:Rabbits
chemical_list: D004337:Drug Carriers; D004317:Doxorubicin